Organizational Costs and Benefits of a Health System Quality Improvement Intervention to Increase Aspirin Use for Primary Prevention of Heart Attack and Stroke.

Performance improvement on clinical quality outcomes typically requires significant effort by personnel in health care organizations. Understanding the cost of quality improvement is important given diffusion of value-based contracting. This study investigates the organizational costs and benefits associated with planning and implementing the Ask about Aspirin intervention to increase use of low-dose aspirin in clinically recommended patient populations. Data from 4 health systems in Minnesota were used to estimate personnel effort and labor resource costs as well as corresponding benefits, measured as the change in aspirin use among eligible candidates during the study period. Overall personnel effort across the 4 systems was approximately 3900 hours with corresponding resource costs estimated to be $214,385. Aspirin use increased 4.7% overall, corresponding to roughly 1530 new users in the aspirin candidate population. Significant variation was observed by system in total hours reported, distribution of effort by activity type, and in benefits realized from the intervention.

[1]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[2]  R. Luepker,et al.  Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980–2009: The Minnesota Heart Survey , 2015, Journal of the American Heart Association.

[3]  R. Luepker,et al.  Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease , 2015, Journal of the American Heart Association.

[4]  J. Gill,et al.  Practice Transformation? Opportunities and Costs for Primary Care Practices , 2013, The Annals of Family Medicine.

[5]  Farzad Mostashari,et al.  Deaths preventable in the U.S. by improvements in use of clinical preventive services. , 2010, American journal of preventive medicine.

[6]  Jacqueline R. Halladay,et al.  Cost to Primary Care Practices of Responding to Payer Requests for Quality and Performance Data , 2009, The Annals of Family Medicine.

[7]  Lisa V Rubenstein,et al.  Organizational cost of quality improvement for depression care. , 2009, Health services research.

[8]  L. Green,et al.  Start-up and incremental practice expenses for behavior change interventions in primary care. , 2008, American journal of preventive medicine.

[9]  A. Algra,et al.  University of Groningen Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age , gender , and varying cardiovascular risk , 2017 .

[10]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[11]  Robert S. Nocon,et al.  The Costs of Participating in a Diabetes Quality Improvement Collaborative: Variation Among Five Clinics. , 2016, Joint Commission journal on quality and patient safety.

[12]  Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.

[13]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.